Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS):A narrative review
Polycystic ovarian syndrome (PCOS) is considered the most common endocrine disorder affecting females. Although it has been primarily studied and discussed in terms of its reproductive symptoms, there are also its cardio-metabolic consequences. PCOS patients are prone to these abnormalities from a very young age, increasing their morbidity and mortality rates. The usual pathogenesis of PCOS is a culmination of several genetic and environmental factors. Regarding its cardio-metabolic aspects, insulin resistance is said to be the single most important cause of a variety of metabolic risk factors, whereas a few other non-traditional factors are also said to be increased in PCOS patients, further increasing their risk of complications due to cardiovascular diseases. A timely diagnosis and treatment of these risk factors by using lifestyle interventions, diet, and/or medications are essential to reduce the burden of PCOS in today’s world.
Modern Medicine – Issue 5 2022
